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To the Editor,
The frequency of invasive fungal infection caused by yeasts
in intensive care units (ICUs) is increasing. Impairment
of the skin and mucosal barrier in the ICUs (catheters,
surgery, intubation etc.), renal failure, parenteral nutrition,
steroid therapy, and use of broad-spectrum antibiotics are
risk factors for invasive candidiasis (1,2). Identification of
the strains is important for treatment, prediction of the
prognosis, and performing infection control measures to
prevent Candida infections (3). In the present study, we
aimed to demonstrate retrospectively the distribution and
antifungal susceptibilities of Candida strains isolated from
the ICU of our hospital.
One hundred and twenty-one Candida isolates
obtained from the ICU between January 2010 and May
2014 were evaluated retrospectively. Recurrent strains
obtained from the same materials in the same patient and
isolates unidentified as to species were not included in the
study. A germ tube test was performed on yeast fungi and
the identification was performed by VITEC 2 Compact
(BioMérieux) system. Susceptibilities of 47 strains to
amphotericin B, flucytosine, fluconazole, voriconazole,
and caspofungin were investigated by VITEC 2 Compact
(BioMérieux) system. Since antifungal susceptibilities
of the strains were studied by using various antifungal
susceptibility test cards of the VITEC 2 automated system,
each antifungal agent was not studied in all strains.
We used VITEC breakpoints for testing the antifungal
susceptibility of Candida species.
A total of 121 Candida strains (65 urine samples,
33 blood samples, 18 deep tracheal aspirate samples, 3
wound samples, and 2 catheter samples) were isolated.
Distribution of the strains was as follows: 82 Candida
albicans (67.8%), 20 Candida parapsilosis (16.5%), 8 C.
tropicalis (6.6%), 6 C. glabrata (5%), 3 C. famata (2.5%),
and 2 C. krusei (1.7%). C. albicans was the most commonly
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isolated Candida species in all sample groups. The second
leading strain is C. parapsilosis in all sample groups. All
of the Candida strains were found to be susceptible to
amphotericin B, caspofungin, and voriconazole. Rates of
resistance to flucytosine and fluconazole were 3.7% and
2.1%, respectively. Intermediate susceptibility (4.3%) to
fluconazole was determined in only C. tropicalis isolates
among all of the strains.
In terms of the distribution of Candida species,
C. albicans was the most commonly isolated strain in
our study. In a study including 1122 Candida strains
performed by Sav et al., C. albicans was the most common
strain, similar to our findings (4). When the Candida
growth in blood cultures in our study was evaluated, the
most commonly isolated strain (42.4%) was C. albicans. C.
parapsilosis (30.3%) was the second leading isolated strain
in our blood cultures. The rate of C. parapsilosis ranged
between 12% and 32% in studies reported from Turkey
about candidemia (5). Non-albicans Candida species were
isolated in 57.6% of our blood cultures. The frequency of
non-albicans Candida species isolated from blood cultures
in our ICU suggests that knowing the distribution of
Candida species in each hospital is important regarding
infection control measures and antifungal treatment. The
presence of different susceptibilities of species to antifungal
agents can be seen with non-albicans Candida species; this
shows that in vitro antifungal susceptibility tests are very
important.
Fluconazole resistance was determined at a rate of
1.4% in 20,576 C. albicans strains and at a rate of 3% in
2406 C. parapsilosis strains (6). The fluconazole resistance
rate was 2.1% in our study, and all Candida strains were
found to be susceptible to voriconazole, caspofungin, and
amphotericin B. In a previous study reported from Turkey,
caspofungin, voriconazole, and amphotericin B resistance
was not determined in any Candida isolates (7).
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In conclusion, voriconazole, caspofungin, and
amphotericin B resistance was not determined in Candida
strains isolated from our ICU. Fluconazole resistance was
not seen in the other strains except C. krusei. C. albicans is
the most commonly encountered Candida strain in our ICU

and fluconazole resistance was not determined. However,
since the distribution of Candida species can change over
time, identification of the isolates and susceptibility tests
for antifungal agents should be performed to enable the
development of resistance to be followed.
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